Industry Research Reports

Home > Reports > Service & Software > Global Gene Site-Directed Mutagenesis Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Gene Site-Directed Mutagenesis Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Service & Software

Published Date: 2026-03-27

Pages: 97 Pages

Report ld: 6001617

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Gene Site-Directed Mutagenesis Services Market Size(US$)

CAGR 2026-2032

5.3%

Market Size,2032

USD 269

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 197 million

Market Forecast in 2032(Value)

US$ 269 million

CAGR

5.3%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Gene Site-Directed Mutagenesis Services market size was US$ 187 million in 2025 and is forecast to reach a readjusted size of US$ 269 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.

Gene Site-Directed Mutagenesis Service is a research outsourcing service based on molecular biology techniques. This service designs specific oligonucleotide primers and uses methods such as PCR (polymerase chain reaction) to introduce precise substitutions, deletions, or insertions at specific nucleotide sites in target genes to simulate naturally occurring mutations or create loss-of-function mutants. Its main purpose is to study the relationship between gene function, protein structure, and activity, or to construct gene expression vectors that meet specific needs. The service provider typically handles the entire process from mutant primer design and plasmid construction to mutant screening and sequencing validation.

The global Gene Site-Directed Mutagenesis Services market is driven by both North America and the Asia-Pacific region. North America, leveraging its mature biotechnology industry chain, boasts numerous specialized companies offering high-throughput, customized mutation services, covering technologies from traditional molecular cloning to advanced CRISPR editing; the market is highly mature. Europe focuses on the integration of technology and basic research, with service providers deeply integrated with structural biology and drug target validation, emphasizing service accuracy and data rigor. The Asia-Pacific region, represented by China, is experiencing rapid growth, utilizing large-scale sequencing platforms and synthetic biology capacity to provide cost-effective, fast services, gradually shifting from low-end contract manufacturing to customized services for complex mutations and model animals.

The global Gene Site-Directed Mutagenesis Services market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

MARKET SEGMENTATION

By Company

Azenta Life Sciences
GenScript
Thermo Fisher Scientific
Charles River Laboratories
Genewiz
Creative Biolabs
NovoPro Bioscience Inc.
ACGT, Inc.
Epoch Life Science
Eurofins Genomics
NZYtech
Synbio Technologies
Tsingke
GenCefe
Generay

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Synonymous Mutations
Missense Mutation
Nonsense Mutation

Segment by Application

Medical Industry
Biological Research
Others

Segment by Category

PCR-Mediated Site-Directed Mutagenesis Service
Homologous Recombination-Based Site-Directed Mutagenesis Service
Single Primer/Whole Plasmid Amplification-Based Mutagenesis Service

Segment by Division

Function Gain/Loss Service
Protein Structure Research Service
Promoter/Regulatory Element Analysis Service
Resistance/Activity Optimization Service
Others

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Gene Site-Directed Mutagenesis Services value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032

1.2.2 Synonymous Mutations

1.2.3 Missense Mutation

1.2.4 Nonsense Mutation

1.3 Market by Application

1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032

1.3.2 Medical Industry

1.3.3 Biological Research

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Site-Directed Mutagenesis Services Market Perspective (2021-2032)

2.2 Global Market Size by Region: 2021 vs 2025 vs 2032

2.3 Global Gene Site-Directed Mutagenesis Services Market Share by Revenue, by Region (2021-2026)

2.4 Global Gene Site-Directed Mutagenesis Services Revenue Forecast by Region (2027-2032)

2.5 Major Regions and Emerging Markets Analysis

2.5.1 North America Gene Site-Directed Mutagenesis Services Market Size and Prospective (2021-2032)

2.5.2 Europe Gene Site-Directed Mutagenesis Services Market Size and Prospective (2021-2032)

2.5.3 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size and Prospective (2021-2032)

2.5.4 Latin America Gene Site-Directed Mutagenesis Services Market Size and Prospective (2021-2032)

2.5.5 Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size and Prospective (2021-2032)

3 Breakdown Data by Type

3.1 Global Gene Site-Directed Mutagenesis Services Historical Market Size by Type (2021-2026)

3.2 Global Gene Site-Directed Mutagenesis Services Forecasted Market Size by Type (2027-2032)

3.3 Representative Players for Different Types of Gene Site-Directed Mutagenesis Services

4 Breakdown Data by Application

4.1 Global Gene Site-Directed Mutagenesis Services Historical Market Size by Application (2021-2026)

4.2 Global Gene Site-Directed Mutagenesis Services Forecasted Market Size by Application (2027-2032)

4.3 New Sources of Growth in Gene Site-Directed Mutagenesis Services Applications

5 Competitive Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Gene Site-Directed Mutagenesis Services Players by Revenue (2021-2026)

5.1.2 Global Gene Site-Directed Mutagenesis Services Market Share by Revenue, by Players (2021-2026)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Gene Site-Directed Mutagenesis Services Revenue

5.4 Global Gene Site-Directed Mutagenesis Services Market Concentration Analysis

5.4.1 Global Gene Site-Directed Mutagenesis Services Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Gene Site-Directed Mutagenesis Services Revenue in 2025

5.5 Global Key Players of Gene Site-Directed Mutagenesis Services Head Offices and Areas Served

5.6 Global Key Players of Gene Site-Directed Mutagenesis Services, Product and Application

5.7 Global Key Players of Gene Site-Directed Mutagenesis Services, Date of Entry into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Gene Site-Directed Mutagenesis Services Revenue by Company (2021-2026)

6.1.2 North America Market Size by Type

6.1.2.1 North America Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026)

6.1.2.2 North America Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2026)

6.1.3 North America Market Size by Application

6.1.3.1 North America Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026)

6.1.3.2 North America Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2026)

6.1.4 North America Gene Site-Directed Mutagenesis Services Major Customers

6.1.5 North America Market Trends and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Gene Site-Directed Mutagenesis Services Revenue by Company (2021-2026)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026)

6.2.2.2 Europe Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2026)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026)

6.2.3.2 Europe Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2026)

6.2.4 Europe Gene Site-Directed Mutagenesis Services Major Customers

6.2.5 Europe Market Trends and Opportunities

6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers

6.3.1 Asia-Pacific Gene Site-Directed Mutagenesis Services Revenue by Company (2021-2026)

6.3.2 Asia-Pacific Market Size by Type

6.3.2.1 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026)

6.3.2.2 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2026)

6.3.3 Asia-Pacific Market Size by Application

6.3.3.1 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026)

6.3.3.2 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2026)

6.3.4 Asia-Pacific Gene Site-Directed Mutagenesis Services Major Customers

6.3.5 Asia-Pacific Market Trends and Opportunities

6.4 Latin America Market: Players, Segments, Downstream and Major Customers

6.4.1 Latin America Gene Site-Directed Mutagenesis Services Revenue by Company (2021-2026)

6.4.2 Latin America Market Size by Type

6.4.2.1 Latin America Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026)

6.4.2.2 Latin America Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2026)

6.4.3 Latin America Market Size by Application

6.4.3.1 Latin America Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026)

6.4.3.2 Latin America Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2026)

6.4.4 Latin America Gene Site-Directed Mutagenesis Services Major Customers

6.4.5 Latin America Market Trends and Opportunities

6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers

6.5.1 Middle East & Africa Gene Site-Directed Mutagenesis Services Revenue by Company (2021-2026)

6.5.2 Middle East & Africa Market Size by Type

6.5.2.1 Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026)

6.5.2.2 Middle East & Africa Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2026)

6.5.3 Middle East & Africa Market Size by Application

6.5.3.1 Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026)

6.5.3.2 Middle East & Africa Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2026)

6.5.4 Middle East & Africa Gene Site-Directed Mutagenesis Services Major Customers

6.5.5 Middle East & Africa Market Trends and Opportunities

7 Key Player Profiles

7.1 Azenta Life Sciences

7.1.1 Azenta Life Sciences Company Details

7.1.2 Azenta Life Sciences Business Overview

7.1.3 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Introduction

7.1.4 Azenta Life Sciences Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026)

7.1.5 Azenta Life Sciences Recent Development

7.2 GenScript

7.2.1 GenScript Company Details

7.2.2 GenScript Business Overview

7.2.3 GenScript Gene Site-Directed Mutagenesis Services Introduction

7.2.4 GenScript Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026)

7.2.5 GenScript Recent Development

7.3 Thermo Fisher Scientific

7.3.1 Thermo Fisher Scientific Company Details

7.3.2 Thermo Fisher Scientific Business Overview

7.3.3 Thermo Fisher Scientific Gene Site-Directed Mutagenesis Services Introduction

7.3.4 Thermo Fisher Scientific Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026)

7.3.5 Thermo Fisher Scientific Recent Development

7.4 Charles River Laboratories

7.4.1 Charles River Laboratories Company Details

7.4.2 Charles River Laboratories Business Overview

7.4.3 Charles River Laboratories Gene Site-Directed Mutagenesis Services Introduction

7.4.4 Charles River Laboratories Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026)

7.4.5 Charles River Laboratories Recent Development

7.5 Genewiz

7.5.1 Genewiz Company Details

7.5.2 Genewiz Business Overview

7.5.3 Genewiz Gene Site-Directed Mutagenesis Services Introduction

7.5.4 Genewiz Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026)

7.5.5 Genewiz Recent Development

7.6 Creative Biolabs

7.6.1 Creative Biolabs Company Details

7.6.2 Creative Biolabs Business Overview

7.6.3 Creative Biolabs Gene Site-Directed Mutagenesis Services Introduction

7.6.4 Creative Biolabs Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026)

7.6.5 Creative Biolabs Recent Development

7.7 NovoPro Bioscience Inc.

7.7.1 NovoPro Bioscience Inc. Company Details

7.7.2 NovoPro Bioscience Inc. Business Overview

7.7.3 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Introduction

7.7.4 NovoPro Bioscience Inc. Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026)

7.7.5 NovoPro Bioscience Inc. Recent Development

7.8 ACGT, Inc.

7.8.1 ACGT, Inc. Company Details

7.8.2 ACGT, Inc. Business Overview

7.8.3 ACGT, Inc. Gene Site-Directed Mutagenesis Services Introduction

7.8.4 ACGT, Inc. Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026)

7.8.5 ACGT, Inc. Recent Development

7.9 Epoch Life Science

7.9.1 Epoch Life Science Company Details

7.9.2 Epoch Life Science Business Overview

7.9.3 Epoch Life Science Gene Site-Directed Mutagenesis Services Introduction

7.9.4 Epoch Life Science Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026)

7.9.5 Epoch Life Science Recent Development

7.10 Eurofins Genomics

7.10.1 Eurofins Genomics Company Details

7.10.2 Eurofins Genomics Business Overview

7.10.3 Eurofins Genomics Gene Site-Directed Mutagenesis Services Introduction

7.10.4 Eurofins Genomics Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026)

7.10.5 Eurofins Genomics Recent Development

7.11 NZYtech

7.11.1 NZYtech Company Details

7.11.2 NZYtech Business Overview

7.11.3 NZYtech Gene Site-Directed Mutagenesis Services Introduction

7.11.4 NZYtech Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026)

7.11.5 NZYtech Recent Development

7.12 Synbio Technologies

7.12.1 Synbio Technologies Company Details

7.12.2 Synbio Technologies Business Overview

7.12.3 Synbio Technologies Gene Site-Directed Mutagenesis Services Introduction

7.12.4 Synbio Technologies Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026)

7.12.5 Synbio Technologies Recent Development

7.13 Tsingke

7.13.1 Tsingke Company Details

7.13.2 Tsingke Business Overview

7.13.3 Tsingke Gene Site-Directed Mutagenesis Services Introduction

7.13.4 Tsingke Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026)

7.13.5 Tsingke Recent Development

7.14 GenCefe

7.14.1 GenCefe Company Details

7.14.2 GenCefe Business Overview

7.14.3 GenCefe Gene Site-Directed Mutagenesis Services Introduction

7.14.4 GenCefe Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026)

7.14.5 GenCefe Recent Development

7.15 Generay

7.15.1 Generay Company Details

7.15.2 Generay Business Overview

7.15.3 Generay Gene Site-Directed Mutagenesis Services Introduction

7.15.4 Generay Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026)

7.15.5 Generay Recent Development

8 Gene Site-Directed Mutagenesis Services Market Dynamics

8.1 Gene Site-Directed Mutagenesis Services Industry Trends

8.2 Gene Site-Directed Mutagenesis Services Market Drivers

8.3 Gene Site-Directed Mutagenesis Services Market Challenges

8.4 Gene Site-Directed Mutagenesis Services Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Global Gene Site-Directed Mutagenesis Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 3. Global Market Gene Site-Directed Mutagenesis Services Market Size (US$ Million) by Region:2021 vs 2025 vs 2032

Table 4. Global Gene Site-Directed Mutagenesis Services Revenue (US$ Million) Market Share by Region (2021-2026)

Table 5. Global Gene Site-Directed Mutagenesis Services Revenue Share by Region (2021-2026)

Table 6. Global Gene Site-Directed Mutagenesis Services Revenue (US$ Million) Forecast by Region (2027-2032)

Table 7. Global Gene Site-Directed Mutagenesis Services Revenue Share Forecast by Region (2027-2032)

Table 8. Global Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026) & (US$ Million)

Table 9. Global Gene Site-Directed Mutagenesis Services Market Share by Revenue, by Type (2021-2026)

Table 10. Global Gene Site-Directed Mutagenesis Services Forecasted Market Size by Type (2027-2032) & (US$ Million)

Table 11. Global Gene Site-Directed Mutagenesis Services Market Share by Revenue, by Type (2027-2032)

Table 12. Representative Players of Each Type

Table 13. Global Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026) & (US$ Million)

Table 14. Global Gene Site-Directed Mutagenesis Services Market Share by Revenue, by Application (2021-2026)

Table 15. Global Gene Site-Directed Mutagenesis Services Forecasted Market Size by Application (2027-2032) & (US$ Million)

Table 16. Global Gene Site-Directed Mutagenesis Services Market Share by Revenue, by Application (2027-2032)

Table 17. New Sources of Growth in Gene Site-Directed Mutagenesis Services Applications

Table 18. Global Gene Site-Directed Mutagenesis Services Revenue by Players (2021-2026) & (US$ Million)

Table 19. Global Gene Site-Directed Mutagenesis Services Market Share by Players (2021-2026)

Table 20. Global Top Gene Site-Directed Mutagenesis Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Site-Directed Mutagenesis Services as of 2025)

Table 21. Ranking of Global Top Gene Site-Directed Mutagenesis Services Companies by Revenue (US$ Million) in 2025

Table 22. Global 5 Largest Players Market Share by Gene Site-Directed Mutagenesis Services Revenue (CR5 and HHI) & (2021-2026)

Table 23. Global Key Players of Gene Site-Directed Mutagenesis Services, Headquarters and Area Served

Table 24. Global Key Players of Gene Site-Directed Mutagenesis Services, Product and Application

Table 25. Global Key Players of Gene Site-Directed Mutagenesis Services, Date of Entry into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Gene Site-Directed Mutagenesis Services Revenue by Company (2021-2026) & (US$ Million)

Table 28. North America Gene Site-Directed Mutagenesis Services Market Share by Revenue, by Company (2021-2026)

Table 29. North America Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026) & (US$ Million)

Table 30. North America Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026) & (US$ Million)

Table 31. Europe Gene Site-Directed Mutagenesis Services Revenue by Company (2021-2026) & (US$ Million)

Table 32. Europe Gene Site-Directed Mutagenesis Services Market Share by Revenue, by Company (2021-2026)

Table 33. Europe Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026) & (US$ Million)

Table 34. Europe Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026) & (US$ Million)

Table 35. Asia-Pacific Gene Site-Directed Mutagenesis Services Revenue by Company (2021-2026) & (US$ Million)

Table 36. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Share by Revenue, by Company (2021-2026)

Table 37. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026) & (US$ Million)

Table 38. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026) & (US$ Million)

Table 39. Latin America Gene Site-Directed Mutagenesis Services Revenue by Company (2021-2026) & (US$ Million)

Table 40. Latin America Gene Site-Directed Mutagenesis Services Market Share by Revenue, by Company (2021-2026)

Table 41. Latin America Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026) & (US$ Million)

Table 42. Latin America Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026) & (US$ Million)

Table 43. Middle East & Africa Gene Site-Directed Mutagenesis Services Revenue by Company (2021-2026) & (US$ Million)

Table 44. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Share by Revenue, by Company (2021-2026)

Table 45. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026) & (US$ Million)

Table 46. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026) & (US$ Million)

Table 47. Azenta Life Sciences Company Details

Table 48. Azenta Life Sciences Business Overview

Table 49. Azenta Life Sciences Gene Site-Directed Mutagenesis Services Product

Table 50. Azenta Life Sciences Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026) & (US$ Million)

Table 51. Azenta Life Sciences Recent Development

Table 52. GenScript Company Details

Table 53. GenScript Business Overview

Table 54. GenScript Gene Site-Directed Mutagenesis Services Product

Table 55. GenScript Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026) & (US$ Million)

Table 56. GenScript Recent Development

Table 57. Thermo Fisher Scientific Company Details

Table 58. Thermo Fisher Scientific Business Overview

Table 59. Thermo Fisher Scientific Gene Site-Directed Mutagenesis Services Product

Table 60. Thermo Fisher Scientific Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026) & (US$ Million)

Table 61. Thermo Fisher Scientific Recent Development

Table 62. Charles River Laboratories Company Details

Table 63. Charles River Laboratories Business Overview

Table 64. Charles River Laboratories Gene Site-Directed Mutagenesis Services Product

Table 65. Charles River Laboratories Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026) & (US$ Million)

Table 66. Charles River Laboratories Recent Development

Table 67. Genewiz Company Details

Table 68. Genewiz Business Overview

Table 69. Genewiz Gene Site-Directed Mutagenesis Services Product

Table 70. Genewiz Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026) & (US$ Million)

Table 71. Genewiz Recent Development

Table 72. Creative Biolabs Company Details

Table 73. Creative Biolabs Business Overview

Table 74. Creative Biolabs Gene Site-Directed Mutagenesis Services Product

Table 75. Creative Biolabs Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026) & (US$ Million)

Table 76. Creative Biolabs Recent Development

Table 77. NovoPro Bioscience Inc. Company Details

Table 78. NovoPro Bioscience Inc. Business Overview

Table 79. NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Product

Table 80. NovoPro Bioscience Inc. Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026) & (US$ Million)

Table 81. NovoPro Bioscience Inc. Recent Development

Table 82. ACGT, Inc. Company Details

Table 83. ACGT, Inc. Business Overview

Table 84. ACGT, Inc. Gene Site-Directed Mutagenesis Services Product

Table 85. ACGT, Inc. Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026) & (US$ Million)

Table 86. ACGT, Inc. Recent Development

Table 87. Epoch Life Science Company Details

Table 88. Epoch Life Science Business Overview

Table 89. Epoch Life Science Gene Site-Directed Mutagenesis Services Product

Table 90. Epoch Life Science Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026) & (US$ Million)

Table 91. Epoch Life Science Recent Development

Table 92. Eurofins Genomics Company Details

Table 93. Eurofins Genomics Business Overview

Table 94. Eurofins Genomics Gene Site-Directed Mutagenesis Services Product

Table 95. Eurofins Genomics Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026) & (US$ Million)

Table 96. Eurofins Genomics Recent Development

Table 97. NZYtech Company Details

Table 98. NZYtech Business Overview

Table 99. NZYtech Gene Site-Directed Mutagenesis Services Product

Table 100. NZYtech Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026) & (US$ Million)

Table 101. NZYtech Recent Development

Table 102. Synbio Technologies Company Details

Table 103. Synbio Technologies Business Overview

Table 104. Synbio Technologies Gene Site-Directed Mutagenesis Services Product

Table 105. Synbio Technologies Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026) & (US$ Million)

Table 106. Synbio Technologies Recent Development

Table 107. Tsingke Company Details

Table 108. Tsingke Business Overview

Table 109. Tsingke Gene Site-Directed Mutagenesis Services Product

Table 110. Tsingke Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026) & (US$ Million)

Table 111. Tsingke Recent Development

Table 112. GenCefe Company Details

Table 113. GenCefe Business Overview

Table 114. GenCefe Gene Site-Directed Mutagenesis Services Product

Table 115. GenCefe Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026) & (US$ Million)

Table 116. GenCefe Recent Development

Table 117. Generay Company Details

Table 118. Generay Business Overview

Table 119. Generay Gene Site-Directed Mutagenesis Services Product

Table 120. Generay Revenue in Gene Site-Directed Mutagenesis Services Business (2021-2026) & (US$ Million)

Table 121. Generay Recent Development

Table 122. Gene Site-Directed Mutagenesis Services Market Trends

Table 123. Gene Site-Directed Mutagenesis Services Market Drivers

Table 124. Gene Site-Directed Mutagenesis Services Market Challenges

Table 125. Gene Site-Directed Mutagenesis Services Market Restraints

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Gene Site-Directed Mutagenesis Services Product Picture

Figure 2. Global Gene Site-Directed Mutagenesis Services Market Share by Type: 2025 vs 2032

Figure 3. Synonymous Mutations Features

Figure 4. Missense Mutation Features

Figure 5. Nonsense Mutation Features

Figure 6. Global Gene Site-Directed Mutagenesis Services Market Share by Application: 2025 vs 2032

Figure 7. Medical Industry

Figure 8. Biological Research

Figure 9. Others

Figure 10. Gene Site-Directed Mutagenesis Services Report Years Considered

Figure 11. Global Gene Site-Directed Mutagenesis Services Market Size (US$ Million), Year-over-Year: 2021-2032

Figure 12. Global Gene Site-Directed Mutagenesis Services Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Gene Site-Directed Mutagenesis Services Market Share by Revenue, by Region: 2021 vs 2025

Figure 14. North America Gene Site-Directed Mutagenesis Services Revenue (US$ Million) Growth Rate (2021-2032)

Figure 15. Europe Gene Site-Directed Mutagenesis Services Revenue (US$ Million) Growth Rate (2021-2032)

Figure 16. Asia-Pacific Gene Site-Directed Mutagenesis Services Revenue (US$ Million) Growth Rate (2021-2032)

Figure 17. Latin America Gene Site-Directed Mutagenesis Services Revenue (US$ Million) Growth Rate (2021-2032)

Figure 18. Middle East & Africa Gene Site-Directed Mutagenesis Services Revenue (US$ Million) Growth Rate (2021-2032)

Figure 19. Global Gene Site-Directed Mutagenesis Services Market Share by Players in 2025

Figure 20. Global Top Gene Site-Directed Mutagenesis Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Site-Directed Mutagenesis Services as of 2025)

Figure 21. The Top 10 and 5 Players Market Share by Gene Site-Directed Mutagenesis Services Revenue in 2025

Figure 22. North America Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2026)

Figure 23. North America Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2026)

Figure 24. Europe Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2026)

Figure 25. Europe Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2026)

Figure 26. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2026)

Figure 27. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2026)

Figure 28. Latin America Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2026)

Figure 29. Latin America Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2026)

Figure 30. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2026)

Figure 31. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2026)

Figure 32. Azenta Life Sciences Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021-2026)

Figure 33. GenScript Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021-2026)

Figure 34. Thermo Fisher Scientific Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021-2026)

Figure 35. Charles River Laboratories Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021-2026)

Figure 36. Genewiz Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021-2026)

Figure 37. Creative Biolabs Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021-2026)

Figure 38. NovoPro Bioscience Inc. Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021-2026)

Figure 39. ACGT, Inc. Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021-2026)

Figure 40. Epoch Life Science Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021-2026)

Figure 41. Eurofins Genomics Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021-2026)

Figure 42. NZYtech Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021-2026)

Figure 43. Synbio Technologies Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021-2026)

Figure 44. Tsingke Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021-2026)

Figure 45. GenCefe Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021-2026)

Figure 46. Generay Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021-2026)

Figure 47. Bottom-up and Top-down Approaches for This Report

Figure 48. Data Triangulation

Figure 49. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 5.3% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

Which companies rank high in the global Gene Site-Directed Mutagenesis Services market? shouQi

What is the annual compound growth rate of the global Gene Site-Directed Mutagenesis Services market size from 2026 to 2032? shouQi

What was the global market size of Gene Site-Directed Mutagenesis Services in 2026? shouQi

What was the global market size of Gene Site-Directed Mutagenesis Services in 2032? shouQi

Related Reports

Global Gene Site-Directed Mutagenesis Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Gene Site-Directed Mutagenesis Services market is projected to grow from US$ 187 million in 2025 to US$ 269 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-27
Pages: 138
USD 4900.00
(Single User License)
Gene Site-Directed Mutagenesis Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Gene Site-Directed Mutagenesis Services was estimated to be worth US$ 187 million in 2025 and is projected to reach US$ 269 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-03-01
Pages: 120
USD 3950.00
(Single User License)
Global Gene Site-Directed Mutagenesis Services Market Research Report 2026
The global Gene Site-Directed Mutagenesis Services market was valued at US$ 187 million in 2025 and is anticipated to reach US$ 269 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-03-01
Pages: 118
USD 2900.00
(Single User License)
Global Gene Site-Directed Mutagenesis Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Gene Site-Directed Mutagenesis Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 97
USD 4250.00
(Single User License)
Global Gene Site-Directed Mutagenesis Services Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Gene Site-Directed Mutagenesis Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 145
USD 4900.00
(Single User License)
Gene Site-Directed Mutagenesis Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gene Site-Directed Mutagenesis Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 102
USD 3950.00
(Single User License)
Global Gene Site-Directed Mutagenesis Services Market Research Report 2025
The global market for Gene Site-Directed Mutagenesis Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 82
USD 2900.00
(Single User License)
Global Gene Site-Directed Mutagenesis Services Market Insights, Forecast to 2030
The global Gene Site-Directed Mutagenesis Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-05-27
Pages: 143
USD 4900.00
(Single User License)
Global and United States Gene Site-Directed Mutagenesis Services Market Report & Forecast 2024-2030
The global Gene Site-Directed Mutagenesis Services revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-05-21
Pages: 107
USD 4350.00
(Single User License)
Gene Site-Directed Mutagenesis Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Gene Site-Directed Mutagenesis Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-05-21
Pages: 114
USD 3950.00
(Single User License)

Global Gene Site-Directed Mutagenesis Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Gene Site-Directed Mutagenesis Services market is projected to grow from US$ 187 million in 2025 to US$ 269 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-27
Pages: 138
USD 4900.00 (Single User License)
Gene Site-Directed Mutagenesis Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Gene Site-Directed Mutagenesis Services was estimated to be worth US$ 187 million in 2025 and is projected to reach US$ 269 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-03-01
Pages: 120
USD 3950.00 (Single User License)
Global Gene Site-Directed Mutagenesis Services Market Research Report 2026
The global Gene Site-Directed Mutagenesis Services market was valued at US$ 187 million in 2025 and is anticipated to reach US$ 269 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-03-01
Pages: 118
USD 2900.00 (Single User License)
Global Gene Site-Directed Mutagenesis Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Gene Site-Directed Mutagenesis Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 97
USD 4250.00 (Single User License)
Global Gene Site-Directed Mutagenesis Services Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Gene Site-Directed Mutagenesis Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 145
USD 4900.00 (Single User License)
Gene Site-Directed Mutagenesis Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gene Site-Directed Mutagenesis Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 102
USD 3950.00 (Single User License)
Global Gene Site-Directed Mutagenesis Services Market Research Report 2025
The global market for Gene Site-Directed Mutagenesis Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 82
USD 2900.00 (Single User License)
Global Gene Site-Directed Mutagenesis Services Market Insights, Forecast to 2030
The global Gene Site-Directed Mutagenesis Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-05-27
Pages: 143
USD 4900.00 (Single User License)
Global and United States Gene Site-Directed Mutagenesis Services Market Report & Forecast 2024-2030
The global Gene Site-Directed Mutagenesis Services revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-05-21
Pages: 107
USD 4350.00 (Single User License)
Gene Site-Directed Mutagenesis Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Gene Site-Directed Mutagenesis Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published: 2024-05-21
Pages: 114
USD 3950.00 (Single User License)